Related by context. Frequent words. (Click for all words.) 64 Application MAA 63 Receives Orphan Drug Designation 63 Nebido 63 Plenaxis R 63 Argatroban 62 DRAXIMAGE 62 mesylate 62 Diosynth Biotechnology 62 Dynepo 62 Ixempra 62 Combidex 62 Orphan Drug status 61 Angiox 61 ATryn ® 61 BioGlue R 61 Helsinn 61 Eligard ® 61 Orphan Drug designation 61 Initiates Phase II 61 supplemental Biologics License Application 61 VALSTAR 61 Eloxatin ® 61 GRNVAC1 60 Hexvix 60 Junovan 60 gets USFDA nod 60 Soliris TM eculizumab 60 BioVectra 60 Medicinal Products EMEA 60 silodosin 60 THALOMID 60 WILEX 60 orphan designation 60 Nexavar ® 60 sterile injectable 60 Loramyc R 60 Aloxi R 59 Canvaxin 59 orphan medicinal product 59 Pirfenidone 59 Rhucin R 59 Diamyd R 59 Initiate Phase 59 Icatibant 59 Pivotal Phase III 59 Diosynth 59 ZALBIN 59 Kuvan R 59 Urocidin 59 faropenem 59 orBec 59 Aegerion 59 TRISENOX 59 Teijin Pharma 59 Meda AB 59 Onalta 59 Swissmedic 59 desvenlafaxine 59 FIRAZYR 58 GMP compliant 58 Kedrion 58 GlaxoSmithKline plc GSK 58 GEM #S 58 Meets Primary Endpoint 58 Multiferon R 58 QRxPharma 58 Metabasis Therapeutics 58 Menarini 58 Urokinase 58 MEPACT 58 amrubicin 58 Vicuron Pharmaceuticals 58 Toctino R 58 Glenmark Generics 58 methylnaltrexone 58 ONTAK 58 BEMA Fentanyl 58 Cetrorelix 58 Release Tablets 58 taliglucerase alfa 58 dalbavancin 58 USFDA approval 58 ATryn R 58 HuMax CD4 58 Rhucin ® 58 bazedoxifene 58 Panzem R 57 Toctino ® 57 Perindopril 57 Merz Pharmaceuticals 57 Marketing Authorization 57 Paladin Labs 57 Zalbin 57 StaphVAX 57 BrachySil 57 Positive Opinion 57 NeutroSpec 57 AVAX 57 Bayer Schering 57 frovatriptan 57 LFB Biotechnologies